BioSpace News Archive

Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will provide a corporate overview at the Bank of America Securities 2021 Virtual Healthcare Conference. The presentation will take place virtually on Tuesday, May 11, 2021, at 3:30 pm. ET.

-- First quarter net sales of $1.847 billion increased 3.6%, 0.8% on a constant currency basis -- First quarter diluted earnings per share were $0.94; adjusted diluted earnings per share were $1.71 -- Full-year 2021 guidance provided - Company expects 14% to 17% revenue growth on a reported basis and 12.5% to 15.5% on a constant currency basis versus 2020

Mainz, Germany,May 4, 2021 – BioNTech SE will announce its financial results for the first quarter 2021 on Monday, May 10th, 2021.

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, announced that Dr. Vimal Mehta, Founder and Chief Executive Officer of BioXcel, will participate in two upcoming virtual healthcare investor conferences.

Checkmate Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, announced that patient dosing was initiated in a Phase 2 trial intended to assess the efficacy and safety of vidutolimod in combination with nivolumab for the treatment of patients with anti-PD-1 refractory advanced melanoma.

Amarin-Supported Research and Analyses from Academic Collaborators to Be Featured in Seven Presentations, Including REDUCE-IT® Heart Failure and Additional Analyses from EVAPORATE

Enrollment continues inPhase 1 clinical trial of lead oncolytic Herpes Simplex Virus (oHSV) viral immunotherapy candidate ONCR-177; initial interim data expected in 2H’21

Oncotelic Therapeutics, Inc., a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health will be working with Chopra Foundation and Heart Care Foundation to provide COVID-19 relief for India, including medicines and oxygen concentrators.

Hillrom announced that its board of directors declared a fiscal 2021 third quarter dividend of $0.24 per share payable on June 30, 2021, to shareholders of record as of the close of business on June 18, 2021.

Bio-Techne Corporation and 908 Devices announced a joint collaboration to develop an extended workflow solution for protein characterization.